Lumacaftor Completed Phase 1 Trials for Cystic Fibrosis (CF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01910415Phase 1, QT/QTC Interval Study in Healthy Subjects
NCT01768663A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
NCT00966602Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects
NCT01216046Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects